InduPro
Latest round
- Series B
Last raised
- Aug 2026
Total raised
- $102M
Investors
- 8
About InduPro
Based in the United States, InduPro, Inc. operates as a biotechnology therapeutics developer. The company provides proximity-guided platforms, bispecific antibody-drug conjugates, T-cell engager programs, and autoimmune and oncology drug candidates. Based in the United States, InduPro, Inc. operates as a biotechnology therapeutics developer. The company provides proximity-guided platforms, bispecific antibody-drug conjugates, T-cell engager programs, and autoimmune and oncology drug candidates. Based in Washington, United States and founded in 2022, InduPro, Inc. provides proximity-based biologic therapeutics for oncology and autoimmune diseases. The company develops therapies by defining and manipulating membrane protein spatial relationships. InduPro, Inc. As of August 2026, the company is founded by K., who joined in April 2024. The company works with biopharmaceutical partners and internal scientific teams to develop proximity-guided therapeutics that target cell surface protein neighborhoods. Its platforms include Membrane Interactomics, MInt, for identifying novel targets and co-target pairings, ARRIS for bringing proteins together using multi-specific antibody technology, and Therapeutic Engineering for protein characterization and optimization. Its pipeline includes IDP-001, a bispecific ADC targeting EGFR and TAPA-E1, plus ADC, T-cell engager, PD1 antagonist, and PD1 agonist programs focused on oncology, immuno-oncology, and autoimmune disease research, with clinical development beginning for IDP-001 in 2026.’s proximity-guided platform, as seen in Sanofi’s preclinical collaboration and Eli Lilly and Company’s global strategic collaboration. Future revenues could also come from milestone payments, option rights, licensing economics, or commercialized drug candidates if programs advance, subject to successful development and approvals. InduPro, Inc. also plans to advance its broader preclinical pipeline across oncology and autoimmune diseases using its proximity-guided discovery platforms and partnerships.
Who invested in InduPro
8 investors across 2 rounds
See all investors in InduPro
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about InduPro
Who invested in InduPro?
InduPro has 8 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has InduPro raised?
InduPro has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did InduPro last raise money?
InduPro's most recent round on record is a Series B, in Aug 2026.
What does InduPro do?
Based in the United States, InduPro, Inc.
Where is InduPro headquartered?
InduPro is headquartered in Seattle, US.
Which VCs invest in companies like InduPro?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Kleiner Perkins and Lightspeed Venture Partners back healthcare companies at InduPro's stage. Their profiles are linked below.
VCs backing healthcare startups at Series B
Raising like InduPro? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.